Please try another search
For the nine months ended 31 December 2019, Nuts Inc revenues increased from Y91M to Y684.6M. Net loss applicable to common stockholders decreased 48% to Y355.3M. Revenues reflect Content Business segment increase of 20% to Y20.5M. Lower net loss reflects Medical Related Business segment income totaling Y110.6M vs. loss of Y291.6M, Eliminations and Corporate segment loss decrease of 46% to Y212.8M.
Period Ending: | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 |
---|---|---|---|---|
Total Revenue | 133.15 | 258.6 | 292.84 | 30.33 |
Gross Profit | 127.54 | 249.48 | 289.49 | 18.7 |
Operating Income | -170.9 | -102.65 | -21.39 | -322.02 |
Net Income | -201.01 | -114.44 | -39.81 | -318.54 |
Period Ending: | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 |
---|---|---|---|---|
Total Assets | 2365.14 | 2096.7 | 1791.44 | 1386.65 |
Total Liabilities | 534.52 | 664.98 | 565.03 | 532.84 |
Total Equity | 1830.62 | 1431.72 | 1226.42 | 853.82 |
Period Ending: | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 |
---|---|---|---|---|
Period Length: | 0 Months | 6 Months | 0 Months | 12 Months |
Cash From Operating Activities | 85.32 | -1193.31 | ||
Cash From Investing Activities | -502.38 | -380.96 | ||
Cash From Financing Activities | 703.46 | -67.42 | ||
Net Change in Cash | 286.4 | -1641.69 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review